Clinical Trial Update: Clostridium Difficile Vaccine Safety, Tolerability, and Immunogenicity Study in Japanese Adults [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability, and immunogenicity of a Clostridioides difficile vaccine in Japanese adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Pfizer Clostridioides difficile vaccine

Snippet

Sponsor: Pfizer | Conditions: Clostridium Difficile Associated Disease | Phase 1 | Status: COMPLETED